FDA Approved: COLESEVELAM — Supplemental Application (Zydus Lifesciences Limited)

View source ↗

Summary

FDA approved a supplemental application for COLESEVELAM submitted by Zydus Lifesciences Limited under ANDA207765.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperlipidemia

Drugs mentioned

• Colesevelam (colesevelam)

Snippet

SUPPL AP for COLESEVELAM (COLESEVELAM)